Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/132505
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | van Belkum, Alex | - |
dc.contributor.author | Bachmann, Till T. | - |
dc.contributor.author | Lüdke, Gerd H. | - |
dc.contributor.author | Lisby, Jan Gorm | - |
dc.contributor.author | Kahlmeter, Gunnar | - |
dc.contributor.author | Mohess, Allan | - |
dc.contributor.author | Becker, Karsten | - |
dc.contributor.author | Hays, John P. | - |
dc.contributor.author | Woodford, Neil | - |
dc.contributor.author | Mitsakakis, Konstantinos | - |
dc.contributor.author | Moran-Gilad, Jacob | - |
dc.contributor.author | Vila Estapé, Jordi | - |
dc.contributor.author | Peter, Harald | - |
dc.contributor.author | Rex, John H. | - |
dc.contributor.author | Dunne Jr., Wm. Michael | - |
dc.date.accessioned | 2019-04-29T14:03:06Z | - |
dc.date.available | 2019-04-29T14:03:06Z | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 1740-1526 | - |
dc.identifier.uri | http://hdl.handle.net/2445/132505 | - |
dc.description.abstract | Antimicrobial susceptibility testing (AST) technologies help to accelerate the initiation of targeted antimicrobial therapy for patients with infections and could potentially extend the lifespan of current narrow-spectrum antimicrobials. Although conceptually new and rapid AST technologies have been described, including new phenotyping methods, digital imaging and genomic approaches, there is no single major, or broadly accepted, technological breakthrough that leads the field of rapid AST platform development. This might be owing to several barriers that prevent the timely development and implementation of novel and rapid AST platforms in health-care settings. In this Consensus Statement, we explore such barriers, which include the utility of new methods, the complex process of validating new technology against reference methods beyond the proof-of-concept phase, the legal and regulatory landscapes, costs, the uptake of new tools, reagent stability, optimization of target product profiles, difficulties conducting clinical trials and issues relating to quality and quality control, and present possible solutions | - |
dc.format.extent | 12 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Nature Publishing Group | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1038/s41579-018-0098-9 | - |
dc.relation.ispartof | Nature Reviews Microbiology, 2019, vol. 17, p. 51-62 | - |
dc.relation.uri | https://doi.org/10.1038/s41579-018-0098-9 | - |
dc.rights | cc by (c) van Belkum, Alex et al., 2019 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Fonaments Clínics) | - |
dc.subject.classification | Tests de sensibilitat microbiològica | - |
dc.subject.classification | Malalties infeccioses | - |
dc.subject.other | Microbial sensitivity tests | - |
dc.subject.other | Communicable diseases | - |
dc.title | Developmental roadmap for antimicrobial susceptibility testing systems | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 684987 | - |
dc.date.updated | 2019-04-29T14:03:06Z | - |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/633780/EU//DIAGORAS | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 30333569 | - |
Appears in Collections: | Articles publicats en revistes (Fonaments Clínics) Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
684987.pdf | 886.18 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License